Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17079562rdf:typepubmed:Citationlld:pubmed
pubmed-article:17079562lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:17079562lifeskim:mentionsumls-concept:C0002895lld:lifeskim
pubmed-article:17079562lifeskim:mentionsumls-concept:C0001617lld:lifeskim
pubmed-article:17079562lifeskim:mentionsumls-concept:C0553692lld:lifeskim
pubmed-article:17079562lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:17079562lifeskim:mentionsumls-concept:C1879316lld:lifeskim
pubmed-article:17079562lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:17079562lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:17079562lifeskim:mentionsumls-concept:C0332185lld:lifeskim
pubmed-article:17079562pubmed:issue5lld:pubmed
pubmed-article:17079562pubmed:dateCreated2006-11-2lld:pubmed
pubmed-article:17079562pubmed:abstractTextPrimary hemorrhagic stroke is an uncommon complication of sickle cell disease, with reported mortality rates of 24% to 65%. Most reported cases are in adults; little is known about its occurrence in children. Proposed risk factors include previous ischemic stroke, aneurysms, low steady-state hemoglobin, high steady-state leukocyte count, acute chest syndrome, and hypertransfusion. We performed a retrospective case-control study to evaluate risk and prognostic factors for primary hemorrhagic stroke among children with sickle cell disease.lld:pubmed
pubmed-article:17079562pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17079562pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17079562pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17079562pubmed:languageenglld:pubmed
pubmed-article:17079562pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17079562pubmed:citationSubsetAIMlld:pubmed
pubmed-article:17079562pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17079562pubmed:statusMEDLINElld:pubmed
pubmed-article:17079562pubmed:monthNovlld:pubmed
pubmed-article:17079562pubmed:issn1098-4275lld:pubmed
pubmed-article:17079562pubmed:authorpubmed-author:DeBaunMichael...lld:pubmed
pubmed-article:17079562pubmed:authorpubmed-author:CasellaJames...lld:pubmed
pubmed-article:17079562pubmed:authorpubmed-author:StrouseJohn...lld:pubmed
pubmed-article:17079562pubmed:authorpubmed-author:HulbertMonica...lld:pubmed
pubmed-article:17079562pubmed:authorpubmed-author:JordanLori...lld:pubmed
pubmed-article:17079562pubmed:issnTypeElectroniclld:pubmed
pubmed-article:17079562pubmed:volume118lld:pubmed
pubmed-article:17079562pubmed:ownerNLMlld:pubmed
pubmed-article:17079562pubmed:authorsCompleteYlld:pubmed
pubmed-article:17079562pubmed:pagination1916-24lld:pubmed
pubmed-article:17079562pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:17079562pubmed:meshHeadingpubmed-meshheading:17079562...lld:pubmed
pubmed-article:17079562pubmed:meshHeadingpubmed-meshheading:17079562...lld:pubmed
pubmed-article:17079562pubmed:meshHeadingpubmed-meshheading:17079562...lld:pubmed
pubmed-article:17079562pubmed:meshHeadingpubmed-meshheading:17079562...lld:pubmed
pubmed-article:17079562pubmed:meshHeadingpubmed-meshheading:17079562...lld:pubmed
pubmed-article:17079562pubmed:meshHeadingpubmed-meshheading:17079562...lld:pubmed
pubmed-article:17079562pubmed:meshHeadingpubmed-meshheading:17079562...lld:pubmed
pubmed-article:17079562pubmed:meshHeadingpubmed-meshheading:17079562...lld:pubmed
pubmed-article:17079562pubmed:meshHeadingpubmed-meshheading:17079562...lld:pubmed
pubmed-article:17079562pubmed:meshHeadingpubmed-meshheading:17079562...lld:pubmed
pubmed-article:17079562pubmed:meshHeadingpubmed-meshheading:17079562...lld:pubmed
pubmed-article:17079562pubmed:meshHeadingpubmed-meshheading:17079562...lld:pubmed
pubmed-article:17079562pubmed:meshHeadingpubmed-meshheading:17079562...lld:pubmed
pubmed-article:17079562pubmed:meshHeadingpubmed-meshheading:17079562...lld:pubmed
pubmed-article:17079562pubmed:year2006lld:pubmed
pubmed-article:17079562pubmed:articleTitlePrimary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids.lld:pubmed
pubmed-article:17079562pubmed:affiliationDivision of Pediatric Hematology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. jstrous1@jhmi.edulld:pubmed
pubmed-article:17079562pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17079562pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:17079562pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:17079562pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17079562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17079562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17079562lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17079562lld:pubmed